Skip to main content

Table 3 Adverse events and grade after switching

From: Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis

Discontinuations patients

n

4 (14%)

Age (Y)

58 ± 11

Gender (M/F)

2 / 2

Dialysis vintage (Y)

17 ± 20

Administration periods (Day)

19 ± 20 (range: 1 – 45)

Reasons of discontinuations

No. of cases (%)

Diarrhea (Grade 1)

2 (3.5%)

Abdominal discomfort (Grade 1)

2 (3.5%)

Constipation (Grade 1)

1 (1.8%)

Nausea (Grade 1)

1 (1.8%)